FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory MCL
On July 24, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to brexucabtagene autoleucel (Tecartus™), a CD19-directed genetically modified autologous T cell immunotherapy, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.
- Read more about FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory MCL
- Add new comment
Meet Your ONS Leader: Bertie A. Field, RN, MS
Get to know Bertie A. Field, RN, MS, ONS Leadership Development Committee member from 2018–2021. Bertie is an oncology account manager for Jazz Pharmaceuticals in Palo Alto, CA.
COVID-19 Legislation Advances Nursing’s Scope of Practice
More than a decade has passed since the Institute of Medicine (now known as the National Academy of Medicine) published its Report on the Future of Nursing in 2010, yet not a great deal has improved.
Insulin Resistance May Explain Racial Disparity in Breast Cancer
Black women with breast cancer typically have a worse prognosis than white women, and the results of a new study suggest that insulin resistance may be a factor in the disparity. Findings from the study were reported in Breast Cancer Research.
The Case of the HPV-Positive Perk
Warren is a 50-year-old man recently diagnosed with human papillomavirus (HPV)-positive oropharyngeal cancer. He and his wife meet with a radiation oncologist and develop a plan of care. Lisa, the radiation oncology nurse, meets with the couple to provide education and answer questions. Darren tells her that two of his “hard living” uncles died from head and neck cancer and the treatment was horrible. He says, “I’ve only had two sexual partners and never smoked—is this cancer really worth treating?”
ONS Director Named Finalist for Pittsburgh’s CIO of the Year
Ryan Conover, the Oncology Nursing Society’s (ONS’s) director of information services, was a finalist for the Pittsburgh Technology Council’s Chief Information Officer (CIO) of the Year. He and 17 other professionals, across five industry categories, were recognized at a virtual awards gala on July 15. Conover was also a finalist in 2016.
What the Evidence Says About Qigong in Patients With Cancer
Qigong is a mind-body practice that originated in China nearly five millennia ago. It integrates movement, meditation, and breath regulation to improve physical and emotional health. The actions are slow, gentle, flowing, repetitious, and weight-bearing and can be adapted or practiced while sitting, standing, or walking. Qigong styles and forms vary widely, depending on the school of thought and philosophy.
Insufficient PPE; COVID-19 and Cancer Mortality Rates; Nurses of Color
Nurses have been advocating for increased personal protective equipment (PPE) long before the COVID-19 coronavirus pandemic. Last year two clinicians published a book that reported on their five years of research into trauma in nurses. Their findings showed that lack of PPE, along with a multitude of other factors, led to a variety of traumas in nurses, all of which has been ignored for decades.
- Read more about Insufficient PPE; COVID-19 and Cancer Mortality Rates; Nurses of Color
- Add new comment
The Case of the Thyroid Tradeoff
Tesla is a 24-year-old woman diagnosed with stage IIIA Hodgkin lymphoma. She enrolled in a clinical trial where she received a combination of chemotherapy and immunotherapy with pembrolizumab, an anti-PD-1 antibody. The clinical trial protocol required three doses every three weeks. At baseline, her thyroid function tests were normal. When she presented for her third dose, her labs showed grade 2 hyperthyroidism.
Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors
Although opioid-related deaths are increasing in the general U.S. population, leading to the U.S. Department of Health and Human Services declaring it a public health emergency, new research shows that the increase is much smaller among patients with cancer, even though opioids are used as an option for cancer-related pain. The findings were published in JAMA Oncology.